Mayne Pharma Group ( (AU:MYX) ) has issued an update.
Mayne Pharma Group has announced that it has ceased to be a substantial holder in a particular company as of March 4, 2025. This change reflects adjustments in the voting securities and associations related to the substantial holder, indicating a shift in the company’s investment strategy or portfolio management.
More about Mayne Pharma Group
YTD Price Performance: 53.30%
Average Trading Volume: 2,637
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $373.2M
See more insights into MYX stock on TipRanks’ Stock Analysis page.